21.20.Z - Manufacture of medicines and other pharmaceutical products
10.89.Z - Manufacture of other food products not elsewhere classified
10.92.Z - Manufacture of prepared pet foods
20.20.Z - Manufacture of pesticides and other agrochemical products
21.10.Z - Manufacture of basic pharmaceutical substances
71.20.B - Other technical testing and analysis
82.92.Z - Packaging activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 2,8 | 3,1 | 0 | -98,5 |
Liabilities and provisions | 7,5 | 10,1 | 6,7 | -33,9 |
Equity | -2,5 | -4,7 | -5,9 | -24,6 |
Total assets | 5 | 5,4 | 0,8 | -85,4 |
Cash and cash equivalents | 0 | 4,6 | 0,6 | -87 |
Depreciation | 0,3 | 0,3 | 0 | -83,7 |
Gross profit / loss | -2,4 | -2,2 | -1,2 | 47,7 |
EBITDA | -2,1 | -1,9 | -1,1 | 42,4 |
Net profit / loss | -2,4 | -2,2 | -1,2 | 47,7 |
Operating profit (EBIT) | -2,4 | -2,2 | -1,2 | 47,7 |
Current assets | 1,7 | 5,3 | 0,8 | -85,1 |
% | % | % | p.p. | |
Return on equity (ROE) | 95,3 | 47 | 19,7 | -27,3 |
Return on sales (ROS) | -86 | -72,6 | -2551,4 | -2478,8 |
Equity ratio | -50,1 | -88 | -752,7 | -664,7 |
EBITDA margin | -74,8 | -63,1 | -2440,5 | -2377,4 |
Gross profit margin | -86 | -72,6 | -2551,4 | -2478,8 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 60 | 378 | 1154 | 776 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.